Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 5/20 | 0.76 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.54 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | TYR | P14679 | 1/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29572116 | 0.87 | PTPN1 (0.88) | PTPN1HSD17B1HSP90AA1TYR | |
| SCHEMBL31121800 | 0.87 | PTPN1 (0.60) | PTPN1HSD17B1HSP90AA1PTGS1TYR | |
| SCHEMBL31121799 | 0.87 | PTPN1 (0.60) | PTPN1HSD17B1HSP90AA1PTGS1TYR | |
| Phaseollidin SCHEMBL1545850 | 0.86 | PTPN1 (0.77) | PTPN1HSD17B1 | |
| Phaseollidin SCHEMBL29349654 | 0.86 | PTPN1 (0.77) | PTPN1HSD17B1 | |
| Erybraedin C SCHEMBL29572548 | 0.85 | PTPN1 (0.77) | PTPN1HSD17B1HSP90AA1 | |
| Erybreadin C SCHEMBL31237899 | 0.85 | PTPN1 (1.00) | PTPN1HSD17B1HSP90AA1 | |
| Erybreadin B SCHEMBL31237953 | 0.83 | PTPN1 (1.00) | PTPN1HSD17B1HSP90AA1 | |
| Erybreadin B SCHEMBL29571677 | 0.83 | PTPN1 (1.00) | PTPN1HSD17B1HSP90AA1 | |
| Licoagrocarpin SCHEMBL30999862 | 0.83 | PTPN1 (0.78) | PTPN1HSD17B1HSP90AA1TYRCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3346842-B1 | STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME | NOVONESIS PLANT BIOSOLUTIONS AS (DK) | 2026-03-25 | — | — | EP | claimed |
| US-11560342-B2 | Bacillus isolates and uses thereof | MONSANTO TECHNOLOGY, LLC (US) | 2023-01-24 | — | — | US | claimed |
| US-20260146009-A1 | Paenibacillus Isolates and Uses Thereof | Novonesis Plant Biosolutions A/S (DK) | 2026-05-28 | — | — | US | disclosed |
| US-12624333-B2 | Stable inoculant compositions and methods for producing same | NOVOZYMES BIOAG A/S (DK) | 2026-05-12 | — | — | US | disclosed |
| US-12612342-B2 | Paenibacillus isolates and uses thereof | NOVOZYMES BIOAG A/S (DK) | 2026-04-28 | — | — | US | disclosed |
| EP-4037457-B1 | SEED TREATER WITH BAFFLES | GUSTAFSON ENG SOLUTIONS LLC (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-3346842-B1 | STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME | NOVONESIS PLANT BIOSOLUTIONS AS (DK) | 2026-03-25 | — | — | EP | disclosed |
| US-20260076287-A1 | Devices For Use In Treating Seeds, And Related Methods | GUSTAFSON ENGINEERED SOLUTIONS LLC | 2026-03-19 | — | — | US | disclosed |
| EP-4658077-A2 | PAENIBACILLUS ISOLATES AND USES THEREOF | Novonesis Plant Biosolutions A/S (DK) | 2025-12-10 | — | — | EP | disclosed |
| EP-3873188-B1 | DEVICE AND METHOD OF TREATING SEEDS | GUSTAFSON ENG SOLUTIONS LLC (US) | 2025-12-03 | — | — | EP | disclosed |
| US-12458017-B2 | Containerized liquid formulations | MONSANTO TECHNOLOGY LLC (US) | 2025-11-04 | — | — | US | disclosed |
| WO-2022208169-A1 | PULSATILE PROTOCOLS FOR CANCER TREATMENT METHODS AND USES | CLINICS OPERATIONS LIMITED (GB) | 2022-10-06 | — | — | WO | disclosed |
| WO-2022207494-A1 | 3-(HETERO)ARYL-5-CHLORODIFLUOROMETHYL-1,2,4-OXADIAZOLE AS FUNGICIDE | BAYER AKTIENGESELLSCHAFT (DE) | 2022-10-06 | — | — | WO | disclosed |
| EP-4061969-A1 | PAENIBACILLUS ISOLATES AND USES THEREOF | Novozymes Bioag A/S (DK) | 2022-09-28 | — | — | EP | disclosed |
| US-20220257561-A1 | COMPOSITIONS AND METHODS FOR IMPROVING WELLNESS | ADVANCED DELIVERY LABS LLC (US) | 2022-08-18 | — | — | US | disclosed |
| EP-4037457-A1 | SEED TREATER WITH BAFFLES AND METHOD OF TREATING SEEDS USING SAME | Monsanto Technology LLC (US) | 2022-08-10 | — | — | EP | disclosed |
| US-20220240519-A1 | MICROBIAL COMPOSITIONS AND METHODS | MONSANTO TECHNOLOGY LLC (US) | 2022-08-04 | — | — | US | disclosed |
| WO-2022125639-A1 | MODIFIED PLANT-ASSOCIATED BACTERIA AND METHODS OF THEIR USE | MONSANTO TECHNOLOGY LLC (US) | 2022-06-16 | — | — | WO | disclosed |
| US-11317633-B2 | Microbial compositions and methods | MONSANTO TECHNOLOGY, LLC (US) | 2022-05-03 | — | — | US | disclosed |
| EP-3634105-B1 | SYSTEM AND METHOD FOR TREATING SEEDS | MONSANTO TECHNOLOGY LLC (US) | 2022-04-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260146009-A1 | Paenibacillus Isolates and Uses Thereof | FBL, NOP2, SPOUT1 | PTPN1 1659/4885HSD17B1 3495/4885HSP90AA1 3248/4885 |
| US-12612342-B2 | Paenibacillus isolates and uses thereof | MASTL, NT5M, FBL | PTPN1 1837/4885HSD17B1 4614/4885HSP90AA1 3118/4885 |
| US-12624333-B2 | Stable inoculant compositions and methods for producing same | UGDH, MGAM, SORD | PTPN1 1849/4885HSD17B1 497/4885HSP90AA1 1161/4885 |
| US-20260076287-A1 | Devices For Use In Treating Seeds, And Related Methods | BROX, TNF, CROCC | PTPN1 800/4885HSD17B1 1006/4885HSP90AA1 1439/4885 |
| US-11560342-B2 | Bacillus isolates and uses thereof | BLVRB, BROX, GLB1 | PTPN1 4068/4885HSD17B1 3514/4885HSP90AA1 1044/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.